Skip to main content
NVDA-2.44%AAPL+3.15%GOOGL+0.44%MSFT-0.14%AMZN-0.22%TSM-1.32%SPCX+0.84%AVGO-0.58%META-1.20%TSLA-0.40%SKHY-4.06%MU-4.40%BRK-B-0.25%LLY-0.13%JPM-0.68%WMT-0.14%AMD-3.07%V-0.22%XOM+0.64%ASMLa-1.66%JNJ-0.16%INTC-4.61%MA-0.60%0700.HK-1.94%1398.HK+0.79%ORCL-3.99%ABBV+0.96%BAC-0.52%CSCO-1.09%CVX-0.39%COST-0.17%KO+0.61%LRCX-4.98%CAT-1.42%AP2d-1.55%0005.HK-0.78%AMAT-2.60%UNH-1.05%HSBA.L-1.30%DELL-3.48%PG+0.46%MS-1.08%GE-0.65%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.26%HD-1.88%0939.HK+1.66%GS-1.16%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.25%USDJPY-1.23%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.97%USDNOK+0.91%USDSEK+0.88%AUDNZD+0.82%EURZAR+0.80%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.71%AUDCAD-0.69%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.61%USDTHB+0.60%CHFNOK+0.57%GBPAUD+0.57%CHFSEK+0.55%AUDSGD-0.54%USDMXN+0.51%USDPLN+0.43%NZDSGD-0.42%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.26%SGDJPY+0.24%AUDCHF-0.23%NZDMXN-0.21%EURHKD-0.18%USDDKK+0.17%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%AUDNOK+0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%EURCNH-0.05%EURCZK-0.05%USDCAD-0.05%USDCOP-0.04%EURGBP+0.04%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.02%EURUSD0.00%EURDKK0.00%XPTUSD-5.92%XAGUSD-5.06%GAGUSD-5.06%UKOIL+4.96%HG1-4.82%USOIL+4.74%XNGUSD+1.63%GAUUSD-1.55%XAUUSD-1.55%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.37%ETHUSD-0.03%USDTUSD-0.02%XRPUSD-2.84%SOLUSD-1.64%TRXUSDT+0.24%ZECUSDT-8.36%DOGEUSD-2.56%XMRUSDT+0.47%LINKUSD-1.12%XLMUSD-1.17%BCHUSDT-9.67%LTCUSD-1.50%UNIUSD-1.03%TONUSD+24.88%HBARUSDT-2.32%SUIUSD-3.99%TAOUSDT-5.17%AAVEUSD-2.21%DOTUSDT-1.56%ICPUSDT-0.72%ONDOUSDT-2.95%WLDUSDT-2.43%ATOMUSDT-2.11%ARBUSDT+0.11%JUPUSDT-3.39%INJUSDT-1.83%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-0.97%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.05%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.41%IOTAUSDT-3.42%AXSUSDT-2.25%FARTCOINUSDT-2.86%EOSUSDT-2.41%DYDXUSDT-1.72%ORDIUSDT-0.35%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.44%AAPL+3.15%GOOGL+0.44%MSFT-0.14%AMZN-0.22%TSM-1.32%SPCX+0.84%AVGO-0.58%META-1.20%TSLA-0.40%SKHY-4.06%MU-4.40%BRK-B-0.25%LLY-0.13%JPM-0.68%WMT-0.14%AMD-3.07%V-0.22%XOM+0.64%ASMLa-1.66%JNJ-0.16%INTC-4.61%MA-0.60%0700.HK-1.94%1398.HK+0.79%ORCL-3.99%ABBV+0.96%BAC-0.52%CSCO-1.09%CVX-0.39%COST-0.17%KO+0.61%LRCX-4.98%CAT-1.42%AP2d-1.55%0005.HK-0.78%AMAT-2.60%UNH-1.05%HSBA.L-1.30%DELL-3.48%PG+0.46%MS-1.08%GE-0.65%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.26%HD-1.88%0939.HK+1.66%GS-1.16%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.25%USDJPY-1.23%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.97%USDNOK+0.91%USDSEK+0.88%AUDNZD+0.82%EURZAR+0.80%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.71%AUDCAD-0.69%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.61%USDTHB+0.60%CHFNOK+0.57%GBPAUD+0.57%CHFSEK+0.55%AUDSGD-0.54%USDMXN+0.51%USDPLN+0.43%NZDSGD-0.42%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.26%SGDJPY+0.24%AUDCHF-0.23%NZDMXN-0.21%EURHKD-0.18%USDDKK+0.17%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%AUDNOK+0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%EURCNH-0.05%EURCZK-0.05%USDCAD-0.05%USDCOP-0.04%EURGBP+0.04%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.02%EURUSD0.00%EURDKK0.00%XPTUSD-5.92%XAGUSD-5.06%GAGUSD-5.06%UKOIL+4.96%HG1-4.82%USOIL+4.74%XNGUSD+1.63%GAUUSD-1.55%XAUUSD-1.55%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.37%ETHUSD-0.03%USDTUSD-0.02%XRPUSD-2.84%SOLUSD-1.64%TRXUSDT+0.24%ZECUSDT-8.36%DOGEUSD-2.56%XMRUSDT+0.47%LINKUSD-1.12%XLMUSD-1.17%BCHUSDT-9.67%LTCUSD-1.50%UNIUSD-1.03%TONUSD+24.88%HBARUSDT-2.32%SUIUSD-3.99%TAOUSDT-5.17%AAVEUSD-2.21%DOTUSDT-1.56%ICPUSDT-0.72%ONDOUSDT-2.95%WLDUSDT-2.43%ATOMUSDT-2.11%ARBUSDT+0.11%JUPUSDT-3.39%INJUSDT-1.83%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-0.97%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.05%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.41%IOTAUSDT-3.42%AXSUSDT-2.25%FARTCOINUSDT-2.86%EOSUSDT-2.41%DYDXUSDT-1.72%ORDIUSDT-0.35%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
IL

Integra LifeSciences Holdings Corporation (IART)

NASDAQ • Healthcare

$16.25
-$0.01 (-0.1%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$16.1
Previous Close$16.25
Day Range$15.99 - $16.46
Avg. Volume (3M)593.4K
Market Cap$1.2B
52 Week Range
$8.7$20.49
Next EarningsIn 49 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$418.7M100%
Gross Profitminus cost of goods$219.7M52%
Operating Incomeminus R&D and overhead$19.2M5%
Net Incomeminus taxes and the rest$4.4M1%

In plain terms: out of every $100 in revenue, Integra LifeSciences Holdings Corporation keeps $1 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1.6B
Net Income (TTM)
-$7.2M
EPS (TTM)
-$0.092
ROA (TTM)
-0.2%
Current Ratio
3.4
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+5.1%Q1 2026$0.83
+31.7%Q2 2026$0.54
+16.5%Q3 2026$0.56
Next

Oct 29

in 49 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation (NASDAQ: IART) develops and sells medical technology for surgery and wound care. In healthcare, the company spans specialty devices, implants, instruments, and biologic repair products, and generated $1.6 billion of revenue in FY2025 across neurosurgical, reconstructive, and wound-care offerings.

Name
Integra LifeSciences Holdings Corporation
CEO
Stuart Essig
Website
www.integralife.com
Industry
Healthcare
Year Founded
1989
Employees
4,427

Today's Snapshot

AI-generated

IART is trading 3.8% below yesterday's close, while its sector was flat. Integra LifeSciences said its business recovery is gaining pace at a healthcare conference.

Trading Volume

Below 10d avg (600.4K)

243.2K

vs S&P 500 Today

Strong Underperformance

-3.20%

Updated: September 10, 2026 at 16:39 UTC

Technical Indicators

2 Buy1 Neutral5 Sell
IART carries a sell bias as short-term momentum indicators and the moving-average picture favor lower prices. RSI is in the low 30s and CCI and MACD are negative, signaling downside momentum, while the stock trades below its 10- and 20-day averages but remains above the 200-day mean, which tempers the signal. ADX near 17 suggests limited trend strength, ATR is moderate at about $0.70, and OBV shows net distribution. The pivot sits above the market, reinforcing near-term resistance. Technical takeaway: short-term technicals favor selling pressure despite a higher long-term average.
All signals
  • EMA (5 indicators)$14.79 - $17.00
    Sell
  • RSI (14)33.77
    Neutral
  • Stochastic %K (14, 3, 3)13.62
    Buy
  • MACD Level (12, 26)-0.40
    Sell

Peers & Related Assets

BFLYButterfly Network, Inc.
$7.46-0.8%
MRVIMaravai LifeSciences Holdings, Inc.
$6.95-3.3%
SEPNSepterna Inc
$37.97+1.6%
FTREFortrea Holdings Inc.
$16.79-1.6%
BCAXBicara Therapeutics Inc. Common Stock
$23.64-0.3%
TNDMTandem Diabetes Care, Inc.
$19.11-3.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.